Latest Partnerships News

Aurora Energy Metals has executed a landmark Option Agreement with Eagle Energy Metals for its flagship Aurora Uranium Project, unlocking up to US$26 million in share consideration and retaining significant exposure through a 40% equity stake. The company also reports improved uranium recovery rates and strategic expansion into Western Australia.

McLaren Minerals has secured critical tenement transfers and completed a heritage survey, setting the stage for drilling at its McLaren Titanium Project in Western Australia. The company is progressing steadily towards a pre-feasibility study expected in Q2 2025.

Aeris Environmental Ltd reported a 5% revenue increase to $766,000 in the December 2024 quarter, driven by strong margins and momentum in its AerisTech joint venture. The company’s expanding customer base and strategic partnerships signal promising growth in smart building solutions and consumables.

Aguia Resources has commenced underground mining at its Santa Barbara gold project and secured a key court victory for its Brazilian phosphate project, supported by a $1.5 million capital raise.

4DS Memory Limited reports successful testing of its 60nm memory cells and progresses toward 20nm technology, alongside a $6 million capital raise and a new design partnership with Infineon.

Elementos Limited reports significant progress in its Oropesa and Cleveland tin projects, positioning itself as a key supplier in Europe amid tightening global tin markets.

Peak Rare Earths Limited has made significant strides in developing its Ngualla Rare Earth Project, completing an $8.5 million capital raise and progressing key negotiations with Shenghe Resources. Community initiatives and asset sales further underpin its growth strategy.

Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.

Akora Resources reports strong progress at its Bekisopa Iron Ore Project in Madagascar, highlighted by successful drilling results, completion of key technical studies, and official support from the Malagasy government. The company is on track to deliver a Pre-Feasibility Study by Q1 2025, aiming to produce high-grade direct shipping ore for steelmakers focused on decarbonisation.

Invion Limited has marked significant progress in its cancer treatment pipeline, dosing the first patient in a pivotal skin cancer trial and reporting encouraging prostate cancer results, while securing fresh funding to support ongoing development.